Related Experiment Video
Updated: May 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Plasma lipid composition and risk of developing cardiovascular disease
Celine Fernandez1, Marianne Sandin, Julio L Sampaio
1Department of Clinical Sciences, Lund University, Malmö, Sweden. Celine.Fernandez@med.lu.se
Specific changes in plasma lipidome, including reduced lysophosphatidylcholine (LPC) and certain triglyceride (TAG) species, are linked to lower cardiovascular disease (CVD) risk. Increased sphingomyelin (SM) levels may indicate higher CVD risk.
Area of Science:
- Lipidomics
- Cardiovascular Disease Research
- Genetics
Background:
- Plasma lipidome alterations may precede cardiovascular disease (CVD) development.
- Genetic factors associated with coronary artery disease (CAD) might influence lipid species levels.
Purpose of the Study:
- To investigate if specific plasma lipidome changes, at similar total lipid levels, predict future CVD events.
- To determine if validated CAD-associated gene variants impact CVD-related lipid species.
Main Methods:
- Top-down shotgun analysis of fasted plasma lipidome.
- Logistic regression comparing incident CVD cases (n=211) and controls (n=216) from the MDC study, adjusting for Framingham risk factors.
- Association analysis between CAD-associated gene variants and plasma lipid species.
Main Results:
- Eight lipid species showed associations with incident CVD (q≤0.23).
- Reduced levels of lysophosphatidylcholine (LPC) species (LPC16:0, LPC20:4) correlated with decreased CVD risk (P=0.024-0.028).
- Increased sphingomyelin (SM) 38:2 was linked to higher CVD odds (P=0.057), while five triglyceride (TAG) species showed protective associations (P=0.031-0.049).
- LPC16:0 levels correlated negatively with carotid intima-media thickness and HbA1c.
- SM38:2 levels correlated positively with LDL-cholesterol.
- Risk alleles of 3 CAD loci were associated with reduced LPC16:0 and/or LPC20:4 levels.
Conclusions:
- CVD development may be preceded by decreased levels of specific lysophosphatidylcholine (LPC) and triglyceride (TAG) species, and increased sphingomyelin (SM) levels.
- Certain lipid species may act as intermediate phenotypes linking genetic susceptibility to overt CVD.
- Findings require replication in larger populations due to loss of statistical significance after multiple testing correction.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis I: Introduction
Lipids: Dietary Sources and Requirements
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...